Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris

PHASE2TerminatedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 1996

Study Completion Date

February 29, 2004

Conditions
Pemphigus Vulgaris
Interventions
DRUG

Dapsone

Trial Locations (8)

10010

The New York VA Medical Center, New York University, New York

19104

University of Pennsylvania, Philadelphia

44106

Case Western Reserve University School of Medicine, Cleveland

48202

Henry Ford Hospital, Detroit

60612

Rush-Presbyterian-St. Luke's Medical Center, Chicago

75235

University of Texas, Dallas

60611-3010

Northwestern University Medical Center, Chicago

08103

Cooper Hospital/University Medical Center, Camden

Sponsors
All Listed Sponsors
lead

Jacobus Pharmaceutical

INDUSTRY